Monitoring for atrial fibrillation in discharged stroke and transient ischemic attack patients: A clinical and cost-effectiveness analysis and review of patient preferences
In-patient cardiac monitoring following a stroke or transient ischemic attack (TIA) captures only a fraction of occult atrial fibrillation (AF) cases, and substantial evidence suggests that the detection rate increases with prolonged monitoring time. To inform decision-makers about the appropriate u...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, March 2016
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | In-patient cardiac monitoring following a stroke or transient ischemic attack (TIA) captures only a fraction of occult atrial fibrillation (AF) cases, and substantial evidence suggests that the detection rate increases with prolonged monitoring time. To inform decision-makers about the appropriate use of outpatient cardiac monitoring devices in patients who have experienced a stroke or TIA, CADTH conducted a health technology assessment (HTA) on the clinical effectiveness and cost-effectiveness of cardiac monitoring devices in outpatient stroke or TIA patients. Patient perspectives and experiences regarding the value and impact of outpatient AF cardiac monitoring devices were also considered |
|---|---|
| Item Description: | "PROSPERO Registration Number: CRD42015025934." |
| Physical Description: | 1 PDF file (136 pages) illustrations |